PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS Russian patent published in 1999 - IPC

Abstract RU 2128172 C1

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to derivatives of pyrazole of the general formula (I) where means phenyl substituted with cyclo(lower)alkyl, hydroxy(lower)alkyl, cyano-, lower alkylenedihydroxy-, carboxy-, (lower alkoxy)carbonyl-group, lower alkanoyl, lower alkanoylhydroxy-, lower alkoxy-, phenoxy-group or carbamoyl optionally substituted with lower alkyl; R2 means halogen, halo(lower)alkyl, cyano-, carboxy-, (lower alkoxy)carbonyl- -group, carbamoyl optionally substituted with alkyl; R3 means phenyl substituted with lower alkylthio-group, lower alkylsulfinyl- or lower alkylsulfonyl-group at condition that if R1 means phenyl substituted with lower alkoxy-group then R2 means halogen or halo(lower)alkyl, or their pharmaceutically acceptable salts. Synthesized compounds show antiinflammatory, antirheumatic and analgetic activity. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 4 cl, 5 dwg, 3 tbl, 33 ex

Similar patents RU2128172C1

Title Year Author Number
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1990
  • Matsuo Masaaki[Jp]
  • Tsudzi Kiesi[Jp]
  • Konisi Nobukie[Jp]
  • Nakamura Katsuja[Jp]
RU2021990C1
CEPHEM COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1992
  • Kazuo Sakane[Jp]
  • Kokhdzi Kavabata[Jp]
  • Kenzi Mijaj[Jp]
  • Esikhiko Inamoto[Jp]
RU2081874C1
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT 1994
  • Khidenori Okhki
  • Masaki Tomisima
  • Akira Jamada
  • Khisasi Takasugi
RU2164230C2
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS 1994
  • Taniguti Kiesi
  • Nagano Masanobu
  • Khattori Kojudzi
  • Tsubaki Kazunori
  • Okitsu Osamu
  • Tabuti Sejitiro
RU2176640C2
DERIVATIVES OF N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE AS ANTAGONISTS OF PLATELET ACTIVATION FACTOR, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT 1994
  • Mitsuru Okhkubo
  • Fumie Takakhasi
  • Tosio Jamanaka
  • Khiroesi Sakai
  • Masajuki Kato
RU2161155C2
CYCLOPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION 1991
  • Tosiro Ivamoto[Jp]
  • Akikhiko Fudzie[Jp]
  • Kumiko Nitta[Jp]
  • Jasukhisa Tsurumi[Jp]
  • Nobukharu Sigematsu[Jp]
  • Tijosi Kasakhara[Jp]
  • Motokhiro Khino[Jp]
  • Masakuni Okukhara[Jp]
  • Kazuo Sakane[Jp]
  • Kokhdzi Kavabata[Jp]
  • Khidenori Okhki[Jp]
RU2108342C1
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TACHYKININ EFFECT 1993
  • Masaaki Matsuo
  • Dajdzhiro Khagivara
  • Khirosi Mijake
RU2119922C1
POLYPEPTIDE COMPOUND, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION 1995
  • Khidenori Oki
  • Masaki Tomisima
  • Akira Jamada
  • Khizasi Takazugi
RU2165423C2
1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR 1994
  • Esio Kavai
  • Khitosi Jamazaki
  • Khirokazu Tanaka
  • Teruo Oku
RU2124517C1
GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS 1994
  • Atsusi Kuno
  • Josikazu Inou
  • Khisasi Takasugi
  • Khiroaki Mizuno
  • Kumi Jamasaki
RU2141946C1

RU 2 128 172 C1

Authors

Masaaki Matsuo

Kijosi Tsudzi

Takasi Ogino

Nobukijo Konisi

Dates

1999-03-27Published

1993-02-04Filed